EBRO 2017

Doses decreased with larger GTVs

Stage N GTV (mL) TTD (Gy) MLD (Gy) I II 79 [10] 71 [10]

48 16 35 64

11 [59] 52 [63] 65 [77] 73 [296]

9 [4] 14 [9] 15 [4] 17 [4]

IIIA IIIB

61 [8] 61 [9]

Figures are means and [SD]

van Baardwijk JCO 2010